A Phase 3 Multicenter, Randomized, Double-Blind and Placebo-Controlled Study, and Open Study of KW-0761 in Patients With HTLV-1 Associated Myelopathy (HAM)
Latest Information Update: 16 Jun 2024
At a glance
- Drugs Mogamulizumab (Primary)
- Indications Spinal cord disorders
- Focus Therapeutic Use
- Sponsors Kyowa Kirin
- 01 Jun 2024 Primary endpoint has not been met (Improvement in Osames motor disability score) , according Results published in the Journal of Neurology
- 01 Jun 2024 Results published in the Journal of Neurology
- 07 Apr 2022 Status changed from completed to discontinued.